C.R. Bard Acquires FlowCardia for Undisclosed Sum
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aa3c0d69-da2a-4bcd-810c-9f0593cecddd&Preview=1 -
Date
5/21/2010 -
Company Name
FlowCardia -
Mailing Address
745 North Pastoria Avenue Sunnyvale, CA 94085 -
Company Description
FlowCardia, Inc. is a medical device company founded in 2002 to design and develop innovative technologies to facilitate the crossing of totally occluded coronary and peripheral arteries. Chronic Total Occlusions (CTOs) are considered one of the last major clinical challenges in interventional therapy. The historic absence of safe and effective CTO recanalization devices and high restenosis rates of bare metal stents in CTOs have been major reasons the majority of CTO patients are still referred to medical management and bypass surgery. -
Website
http://www.flowcardia.com -
Transaction Type
M&A -
Transaction Amount
Undisclosed -
Transaction Round
-
Proceeds Purposes
-
M&A Terms
Financial terms of the transaction were not disclosed
